S&P 500   3,745.47 (-1.00%)
DOW   29,939.52 (-1.10%)
QQQ   280.45 (-0.54%)
AAPL   145.71 (-0.47%)
MSFT   247.45 (-0.70%)
META   139.51 (+0.38%)
GOOGL   101.71 (+0.28%)
AMZN   120.68 (-0.22%)
TSLA   239.37 (-0.60%)
NVDA   131.81 (-0.21%)
NIO   14.92 (-6.98%)
BABA   84.59 (+0.24%)
AMD   68.15 (+0.31%)
T   15.37 (-3.52%)
MU   54.87 (+0.26%)
CGC   3.67 (+19.54%)
F   12.37 (-1.12%)
GE   66.35 (-1.62%)
DIS   100.19 (-0.61%)
AMC   7.20 (-1.77%)
PYPL   94.58 (+0.80%)
PFE   43.11 (-2.29%)
NFLX   241.01 (+1.81%)
S&P 500   3,745.47 (-1.00%)
DOW   29,939.52 (-1.10%)
QQQ   280.45 (-0.54%)
AAPL   145.71 (-0.47%)
MSFT   247.45 (-0.70%)
META   139.51 (+0.38%)
GOOGL   101.71 (+0.28%)
AMZN   120.68 (-0.22%)
TSLA   239.37 (-0.60%)
NVDA   131.81 (-0.21%)
NIO   14.92 (-6.98%)
BABA   84.59 (+0.24%)
AMD   68.15 (+0.31%)
T   15.37 (-3.52%)
MU   54.87 (+0.26%)
CGC   3.67 (+19.54%)
F   12.37 (-1.12%)
GE   66.35 (-1.62%)
DIS   100.19 (-0.61%)
AMC   7.20 (-1.77%)
PYPL   94.58 (+0.80%)
PFE   43.11 (-2.29%)
NFLX   241.01 (+1.81%)
S&P 500   3,745.47 (-1.00%)
DOW   29,939.52 (-1.10%)
QQQ   280.45 (-0.54%)
AAPL   145.71 (-0.47%)
MSFT   247.45 (-0.70%)
META   139.51 (+0.38%)
GOOGL   101.71 (+0.28%)
AMZN   120.68 (-0.22%)
TSLA   239.37 (-0.60%)
NVDA   131.81 (-0.21%)
NIO   14.92 (-6.98%)
BABA   84.59 (+0.24%)
AMD   68.15 (+0.31%)
T   15.37 (-3.52%)
MU   54.87 (+0.26%)
CGC   3.67 (+19.54%)
F   12.37 (-1.12%)
GE   66.35 (-1.62%)
DIS   100.19 (-0.61%)
AMC   7.20 (-1.77%)
PYPL   94.58 (+0.80%)
PFE   43.11 (-2.29%)
NFLX   241.01 (+1.81%)
S&P 500   3,745.47 (-1.00%)
DOW   29,939.52 (-1.10%)
QQQ   280.45 (-0.54%)
AAPL   145.71 (-0.47%)
MSFT   247.45 (-0.70%)
META   139.51 (+0.38%)
GOOGL   101.71 (+0.28%)
AMZN   120.68 (-0.22%)
TSLA   239.37 (-0.60%)
NVDA   131.81 (-0.21%)
NIO   14.92 (-6.98%)
BABA   84.59 (+0.24%)
AMD   68.15 (+0.31%)
T   15.37 (-3.52%)
MU   54.87 (+0.26%)
CGC   3.67 (+19.54%)
F   12.37 (-1.12%)
GE   66.35 (-1.62%)
DIS   100.19 (-0.61%)
AMC   7.20 (-1.77%)
PYPL   94.58 (+0.80%)
PFE   43.11 (-2.29%)
NFLX   241.01 (+1.81%)
TSE:HRX

Héroux-Devtek - HRX Stock Forecast, Price & News

C$11.52
-0.93 (-7.47%)
(As of 10/6/2022 03:39 PM ET)
Add
Compare
Today's Range
C$11.48
C$12.35
50-Day Range
C$11.76
C$14.65
52-Week Range
C$11.48
C$19.40
Volume
34,084 shs
Average Volume
26,132 shs
Market Capitalization
C$397.23 million
P/E Ratio
16.00
Dividend Yield
N/A
Price Target
C$20.25

Héroux-Devtek MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
74.1% Upside
C$20.25 Price Target
Short Interest
N/A
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Acquiring Shares
C$10,784 Bought Last Quarter
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.15 out of 5 stars

HRX stock logo

About Héroux-Devtek (TSE:HRX) Stock

Héroux-Devtek Inc. engages in the design, development, manufacture, assembling, and repair and overhaul of aircraft landing gears, hydraulic and electromechanical flight control actuators, custom ball screws, and fracture-critical components. The company also assembles and installs aircraft components at customer assembly lines. In addition, it offers electro-mechanical linear actuation systems; design, engineering, and product support services; surface treatment services; and electronic enclosures, heat exchangers, cabinets, and titanium components. The company serves commercial and defense sectors of the aerospace industries. It operates in Canada, the United States, the United Kingdom, Rest of Europe, Spain, and internationally. The company was formerly known as Heroux Inc. and changed its name to Héroux-Devtek Inc. in 2000. Héroux-Devtek Inc. was incorporated in 1942 and is headquartered in Longueuil, Canada.

Receive HRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Héroux-Devtek and its competitors with MarketBeat's FREE daily newsletter.

HRX Stock News Headlines

HRX:CA Héroux-Devtek Inc.
HÉROUX-DEVTEK REPORTS FIRST QUARTER RESULTS
HÉROUX-DEVTEK ANNOUNCES MAJOR MULTI-YEAR CONTRACT
Heroux-Devtek Inc Stock Quote HRX
Stocks in play: Héroux-Devtek Inc.
What Is Héroux-Devtek Inc.'s (TSE:HRX) Share Price Doing?
Is Héroux-Devtek Inc. (TSE:HRX) Popular Amongst Insiders?
See More Headlines
Receive HRX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Héroux-Devtek and its competitors with MarketBeat's FREE daily newsletter.

HRX Company Calendar

Last Earnings
5/25/2017
Today
10/06/2022
Next Earnings (Estimated)
11/11/2022

Industry, Sector and Symbol

Industry
Aerospace & Defense
Sub-Industry
N/A
CIK
N/A
Fax
N/A
Employees
2,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
C$20.25
High Stock Price Forecast
C$23.00
Low Stock Price Forecast
C$18.00
Forecasted Upside/Downside
+75.8%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
C$523.99 million
Cash Flow
C$2.51 per share
Book Value
C$10.66 per share

Miscellaneous

Free Float
N/A
Market Cap
C$397.23 million
Optionable
Not Optionable
Beta
N/A

Key Executives

  • Mr. Gilles Labbe F.C.A. (Age 66)
    FCA, FCPA, Exec. Chairman
    Comp: $953.38k
  • Mr. Martin Brassard
    Pres, CEO & Director
  • Mr. Stéphane Arsenault C.A.
    CPA, CPA, CA, CFO & VP
  • Jean-Philippe Sanche
    VP of Legal Affairs
  • Mr. Jean Gravel
    Vice-Pres of Sales & Program Management
  • Mr. Stéphane Rainville
    VP of HR
  • Mr. Gaétan Roy
    Managing Director of UK Runcorn - Landing Gear
  • Guinn D. Crousen
    Pres of Progressive Incorporated - Aerostructure Division
  • Mr. François Renaud
    Corp. Sec.
  • Patrick Gagnon
    VP & Corp. Controller













HRX Stock - Frequently Asked Questions

Should I buy or sell Héroux-Devtek stock right now?

3 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Héroux-Devtek in the last twelve months. There are currently 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" HRX shares.
View HRX analyst ratings
or view top-rated stocks.

What is Héroux-Devtek's stock price forecast for 2022?

3 brokerages have issued 12-month price objectives for Héroux-Devtek's stock. Their HRX share price forecasts range from C$18.00 to C$23.00. On average, they predict the company's share price to reach C$20.25 in the next year. This suggests a possible upside of 62.7% from the stock's current price.
View analysts price targets for HRX
or view top-rated stocks among Wall Street analysts.

How have HRX shares performed in 2022?

Héroux-Devtek's stock was trading at C$18.00 on January 1st, 2022. Since then, HRX stock has decreased by 30.8% and is now trading at C$12.45.
View the best growth stocks for 2022 here
.

When is Héroux-Devtek's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, November 11th 2022.
View our HRX earnings forecast
.

How were Héroux-Devtek's earnings last quarter?

Héroux-Devtek Inc. (TSE:HRX) released its earnings results on Thursday, May, 25th. The company reported $0.25 earnings per share for the quarter, topping the consensus estimate of $0.22 by $0.03. The company earned $120.89 million during the quarter, compared to analysts' expectations of $121.50 million.

What other stocks do shareholders of Héroux-Devtek own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Héroux-Devtek investors own include Enbridge (ENB), Bank of Nova Scotia (BNS), Manulife Financial (MFC), Stella-Jones (SJ), BCE (BCE), Semafo (SMF), TELUS (T), Toronto-Dominion Bank (TD), WSP Global (WSP) and AltaGas (ALA).

What is Héroux-Devtek's stock symbol?

Héroux-Devtek trades on the Toronto Stock Exchange (TSX) under the ticker symbol "HRX."

How do I buy shares of Héroux-Devtek?

Shares of HRX stock and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian stock market include BMO InvestorLine, CIBC Investor's Edge, Desjardins Online Brokerage, HSBC InvestDirect, Laurentian Bank Discount Brokerage, National Bank Direct Brokerage, Qtrade Investor, Questrade, RBC Direct Investing, Scotia iTrade, TD Direct Investing, and Virtual Brokers.
Compare Top Brokerages Here.

What is Héroux-Devtek's stock price today?

One share of HRX stock can currently be purchased for approximately C$12.45.

How much money does Héroux-Devtek make?

Héroux-Devtek (TSE:HRX) has a market capitalization of C$429.30 million and generates C$523.99 million in revenue each year.

How many employees does Héroux-Devtek have?

The company employs 2,100 workers across the globe.

How can I contact Héroux-Devtek?

Héroux-Devtek's mailing address is East Tower 1111 Saint-Charles St W Suite 658, LONGUEUIL, QC J4K 5G4, Canada. The official website for the company is www.herouxdevtek.com. The company can be reached via phone at +1-450-6793330.

This page (TSE:HRX) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.